Item 7.01 Regulation FD Disclosure

Share Repurchase Authorization

On May 7, 2009, the Company announced that the Board of Directors for PSS World Medical, Inc. ("the Company") authorized the purchase of its outstanding common shares. Depending on current market conditions and other factors, the Company is authorized to repurchase up to a maximum of 5% of its total common stock, or approximately 3.0 million common shares, in the open market, privately negotiated transactions, and other transactions that will be disclosed publicly through filings with the Securities and Exchange Commission (SEC). This authorization is in addition to any shares remaining available under existing repurchase programs. As of March 31, 2009, the Company had approximately 59.3 million total issued and outstanding common shares.

---